Drug Profile
Research programme: bioactive lipid-based therapeutics - Ono Pharmaceutical/Tohoku University/University of Tokyo
Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Ono Pharmaceutical; Tohoku University; University of Tokyo
- Class Lipids
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Undefined in Japan
- 13 Mar 2014 Research programme: bioactive lipid-based therapeutics - Ono Pharmaceutical/Tohoku University/University of Tokyo is available for licensing in World as of 13 Mar 2014. http://www.ono.co.jp
- 06 Mar 2014 Early research in Undefined indication in Japan (unspecified route)